13 completed, 2 terminated, 1 unknown. 16 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 16 | Completed 13, Terminated 2, Unknown 1 |
Follow fesoterodine: new trials by email Literature Review of fesoterodine trials Research Report on fesoterodine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine - Urinary Incontinence, Urgency Urinary | Phase 4 | Completed | Brigham and Women's Hospital | 20 | 2019-10-30 | 2022-11-15 |
| Fesoterodine on Urgency Episodes in Parkinson's Disease Population Fesoterodine, Placebo - Urinary Bladder, Overactive, Parkinson Disease | Phase 4 | Terminated | Sir Mortimer B. Davis - Jewish General Hospital | 5 | 2016-09-01 | 2019-09-26 |
| Fall Prevention in Older Adults With OAB Fesoterodine - Overactive Bladder | Phase 4 | Completed | University of Pennsylvania | 74 | 2015-07-25 | 2023-05-06 |
| Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate Fesoterodine fumarate, Placebo, Percutaneous Tibial Nerve Stimulation (PTNS) - Overactive Bladder | Phase 4 | Terminated | Mayo Clinic | 4 | 2012-06-01 | 2014-02-05 |
| Premarin Versus Toviaz for Treatment of Overactive Bladder Toviaz, Premarin, Placebo cream - Overactive Bladder | Phase 4 | Unknown | The Cleveland Clinic | 90 | 2012-04-01 | 2017-04-20 |
| A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy Fesoterodine, Placebo oral tablet - Prostate Adenocarcinoma | Phase 4 | Completed | Abramson Cancer Center at Penn Medicine | 3 | 2012-01-01 | 2020-04-28 |
| A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. Fesoterodine 8 mg, Placebo - Urinary Bladder, Overactive | Phase 4 | Completed | Pfizer | 990 | 2011-05-01 | 2018-12-04 |
| A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine Fesoterodine 8mg, Fesoterodine 4mg, Placebo - Overactive Bladder | Phase 4 | Completed | Pfizer | 2012 | 2011-05-01 | 2014-03-26 |
| Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder Imidafenacin, Fesoterodine - Overactive Bladder | Phase 4 | Completed | LG Life Sciences | 207 | 2010-12-01 | 2012-04-16 |
| Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder Fesoterodine - Urinary Bladder, Overactive | Phase 4 | Completed | Pfizer | 31 | 2010-05-01 | 2013-05-15 |
| An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Toviaz (Fesoterodine) - Bladder Outlet Obstruction | Phase 4 | Completed | Weill Medical College of Cornell University | 17 | 2010-01-01 | 2018-04-10 |
| A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder Fesoterodine, Placebo - Overactive Bladder | Phase 4 | Completed | Pfizer | 566 | 2009-09-01 | 2013-01-17 |
| A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency Fesoterodine, Placebo - Overactive Bladder | Phase 4 | Completed | Pfizer | 963 | 2009-08-01 | 2018-12-04 |
| UK Study Assessing Flexible Dose Fesoterodine in Adults Fesoterodine - Urinary Bladder, Overactive | Phase 4 | Completed | Pfizer | 331 | 2009-02-01 | 2011-01-26 |
| Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) Fesoterodine, Matching Placebo - Urge Urinary Incontinence, Overactive Bladder | Phase 4 | Completed | University of California, San Francisco | 645 | 2009-01-01 | 2011-11-24 |
| A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. Placebo, Fesoterodine fumarate - Urinary Bladder, Overactive | Phase 4 | Completed | Pfizer | 794 | 2008-06-01 | 2011-12-14 |
Urinary Bladder, Overactive (13) · Urinary Incontinence, Urge (2) · Parkinson Disease (1) · Urinary Bladder Neck Obstruction (1) · Urinary Incontinence (1)
Pfizer (7) · Abramson Cancer Center at Penn Medicine (1) · Brigham and Women's Hospital (1) · LG Life Sciences (1) · Mayo Clinic (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · The Cleveland Clinic (1) · University of California, San Francisco (1) · University of Pennsylvania (1) · Weill Medical College of Cornell University (1)
United States (10) · Canada (3) · Finland (3) · Germany (3) · South Korea (3) · Sweden (3) · United Kingdom (3) · Czechia (2) · Denmark (2) · Egypt (2) · Hungary (2) · Italy (2) · Mexico (2) · Norway (2) · Poland (2)
Alexandriah Alas, MD (1) · Alexis Te, MD (1) · David Lee, MD (1) · Eric Hurtado, MD (1) · Jeanette S. Brown, MD (1) · Jeffrey Cornella, MD (1) · Lysanne Campeau, MD, PhD (1) · Vatche Minassian, MD, MPH (1)
PMID 37160401, PMID 35881009, PMID 23460503, PMID 23973522, PMID 24552358, PMID 24898471, PMID 29324595, PMID 34807883